@subatomicdoc @TimAllenMDJD Found it. Sorry so late! https://t.co/2Co22YZs8O
RT @abcdiagnosis: @METUPUKorg @LesleycStephen have I sent you this? X https://t.co/r7y59O6NP8
@METUPUKorg @LesleycStephen have I sent you this? X
RT @zmadak: Metastatic breast cancer: Many authors are involved in translational research, basic scientists and clinicians https://t.co/t5F…
RT @zmadak: Metastatic breast cancer: Many authors are involved in translational research, basic scientists and clinicians https://t.co/t5F…
Metastatic breast cancer: Many authors are involved in translational research, basic scientists and clinicians https://t.co/t5FGRJqJhv #rad19
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
Breast cancer brain metastases commonly acquire alterations in clinically actionable genes, which has immediate clinical implications. https://t.co/MkMJYEkdfY
#BreastCancer gene profile can change overtime. Eg., HER2 neg tumor may become HER2+ when it metastasizes to the brain. https://t.co/khdLfJDODG
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
20% of ERBB2/HER2-negative primary tumors become ERBB2/HER2-positive in brain mets of #breastcancer https://t.co/ca1F62KcZQ https://t.co/sd4PfUu32S
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
RT @JAMAOnc: Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGw…
Brain mets in #BreastCancer frequently develop clinically relevant, suggesting value to molecular profiling https://t.co/vIRGwwIzAL #BCSM
RT @joostverhoeff: Hersenmetastasen borstkanker bij 1 op de 5 patiënten her2 positief terwijl borsttumor her2 negatief was. Consequenties v…
RT @thecancergeek: Now isn’t this interesting - HER2 amplification or gain of mutation in brain mets from previously HER2 neg primary BCs.…
RT @thecancergeek: Now isn’t this interesting - HER2 amplification or gain of mutation in brain mets from previously HER2 neg primary BCs.…
Now isn’t this interesting - HER2 amplification or gain of mutation in brain mets from previously HER2 neg primary BCs. 20% of the time. https://t.co/XvgYRPBREu
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/IvZAhHNpye
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @ktmontone: Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/94aNBjrzpL
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @ktmontone: Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/94aNBjrzpL
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
#bcsm #camets #camoldx #btsm BrCA mets acquired HER2 alterations in ~20% of HER2-negative case https://t.co/bHqmbnbqPY
#bcsm #camets #camoldx #btsm BrCA mets acquiredHER2 alterations in ~20% of HER2-negative case https://t.co/bHqmbnbqPY
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @ktmontone: Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/94aNBjrzpL
Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/94aNBjrzpL
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
Hersenmetastasen borstkanker bij 1 op de 5 patiënten her2 positief terwijl borsttumor her2 negatief was. Consequenties voor behandelopties. https://t.co/sltxUrcWMn
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/y59iv3sNSb
Brain mets not = body mets. Fresh analysis reveals novel vulnerabilities https://t.co/KOYxOnKmvD
https://t.co/YYwwwKU01u 脳転移を切除して検索した結果
Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/QMr8iPsNvC
RT @NatRevClinOncol: Intrinsic-subtype switching & acquired HER2 amplifications/mutations not uncommon in #breastcancer brain metastases: h…
20% of HER2-negative primary tumors switching to HER2-positive in brain mets. https://t.co/h0GaYVkMGQ
RT @npriedig: Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain…
RT @npriedig: Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain…
RT @npriedig: Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain…
RT @npriedig: Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain…
RT @npriedig: Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain…
Inspired by @dgmacarthur lab, see https://t.co/9xuVH68lkv to reproduce figs from @JAMAOnc paper on HER2 gains in #brca brain mets #opendata https://t.co/BrrqKWsjWH
Strong evidence increasing case for genomic testing of metastases—potentially clinically actionable! https://t.co/E1xJzIT7E0
Breast cancer brain mets acquire ERBB2 alterations. https://t.co/awXQmd1sJA @myESMO @JAMAOnc
RT @rschilsky: Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/9eIdd9rOMF
Breast Cancer Brain Metastases and ERBB2/HER2 Activating Mutations https://t.co/9eIdd9rOMF
RT @NatRevClinOncol: Intrinsic-subtype switching & acquired HER2 amplifications/mutations not uncommon in #breastcancer brain metastases: h…
Intrinsic-subtype switching & acquired HER2 amplifications/mutations not uncommon in #breastcancer brain metastases: https://t.co/NeUA1lBNoq
RT @DrRobertOConnor: Brain metastasis can B a huge challenge in breast cancer. This research gives new understanding of what going on & pos…
Brain metastasis can B a huge challenge in breast cancer. This research gives new understanding of what going on & possible new treatments https://t.co/Q5wdq62y90
Likely very important & practice changing research coming out today from our @IrishCancerSoc funded @BREAST_PREDICT https://t.co/afmSE9Rz1w
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @npriedig: Our work on HER2/other gains in breast cancer brain mets out in @JAMAOnc @Adrianvlee @oesterreichs @AhmedBasudan1 @wattersrj…
Early molecular changes in breast cancer with brain metastases should be used to diagnosis and targeted therapies. https://t.co/pObhuBADvH https://t.co/dFHj1VA00v
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
RT @JAMAOnc: Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9
Breast Cancer Brain Metastases and ERBB2 / HER2 Activating Mutations https://t.co/tLTI6gs9F9